Wednesday, September 27, 2017

Pentec Health Provides Specialty Infusion Services


An experienced executive with a proven record as a turnaround specialist and business strategist, Joe Cosgrove currently serves Pentec Health, Inc., as its president, CEO, and director. A graduate of Rowan University in Glassboro, New Jersey, he has spent his career in positions of progressively increasing responsibility and authority within the pharmaceutical and health care industry. Joe Cosgrove was vice president and general manager of Cardinal Health’s global pharmaceutical and supply chain services prior to his current position at Pentec Health.

Established in 1983 as Pentec Infusions, the firm is a leading provider of renal nutrition, such as intraperitoneal nutrition and intradialytic parenteral nutrition therapies performed for dialysis patients, as well as other specialty infusion and pharmacy services. The company’s specialty infusion division, which supports clients who have implanted intrathecal pumps, is accredited for home care by the Joint Commission and provides in-home care for patients with a broad range of disorders, including stroke, spinal cord injury, cancer pain, cerebral palsy, multiple sclerosis, and other painful or debilitating conditions.

Pentec Health’s specialty pharmacy compounds sterile medications that are custom made for each individual patient in accordance with the prescribing physician’s exact specifications. In addition to preparing such traditional compounds as pain management medications, antibiotics, total parenteral nutrition, and intravenous immunoglobulins, the pharmacy also prepares preservative-free medications for patients with implanted infusion pumps and concentrates on nutritional compounds for dialysis patients. More information about the company is available on its website at www.pentechealth.com.

Wednesday, September 20, 2017

Pentec Health Named a 2014 Fastest Growing Company by Inc. Magazine


A seasoned executive in the pharmaceutical industry, Joe Cosgrove possesses more than two decades of experience in the sector. Joe Cosgrove currently serves as the chairman and president of Pentec Health, Inc.

Established more than three decades ago, Pentec Health is a provider of specialty infusion services. The company focuses on supplying patients with compounded prescription pharmaceutical products. Accredited by The Joint Commission, Pentec provides dialysis patients IPN and IDPN products to treat malnutrition and low serum albumin levels. In addition, its full-service specialty infusion division supports patients suffering from a range of ailments, such as cerebral palsy, failed back syndrome, and spinal cord injury.

In August of 2014, Pentec Health was named among the nation’s fastest growing private companies by Inc. Magazine. This marked the fifth consecutive time the firm made the list of 5,000 notable US companies; the list also included Under Armour, Clif Bar, Oracle, and Intuit. The organization’s chairman recognizes the success is due to the company’s unwavering commitment to providing a flawless patient experience. 

To learn more about the company, visit www.pentechealth.com.

Wednesday, September 13, 2017

Overview of Home Infusion Therapy


Since 2008, Joe Cosgrove has been the CEO, president, and chairman of the board of directors for Pentec Health Incorporated of Boothwyn, Pennsylvania, a specialty sterile compounding pharmacy company providing infusion services to patients in the home and other various alternate administration sites. Joe Cosgrove also serves as a board member for the National Home Infusion Association (NHIA). 

Home infusion therapy involves administering medication via a catheter or needle, and it is primarily used in severe conditions where oral medication is not an option. In order to deliver home infusion therapy, medical facilities must be licensed and able to administer specific types of drugs. Infusion therapy often involves antibiotics, pain medications, chemotherapy, and nutritional supplements. 

Up until the 1980s, infusion therapy was done exclusively in inpatient settings. After this time, when a higher emphasis was placed on reducing costs and advancing medical technology, infusion therapy could be administered without interrupting a patient’s everyday life. Home infusion therapy has been proven a safe and effective way to administer treatment and a viable option to very costly inpatient care.

Monday, September 11, 2017

Patients with Nutritional Restrictions Benefit from PROPLETE Formula


Since taking on the role of chairman and chief executive officer at Pentec Health in 2008, Joe Cosgrove has led a number of major initiatives and propelled significant growth. As one of Pentec Health’s most important product launches under Joe Cosgrove’s leadership, PROPLETE has helped hundreds of thousands of people mitigate the effects of kidney disease.

PROPLETE, an intradialytic parenteral nutrition therapy for patients undergoing dialysis, provides protein supplements without additional calories. This helps ensure that patients who consume inadequate protein but sufficient calories in their diets receive necessary nutrients for tissue synthesis without excessive lipids or carbohydrates. 

PROPLETE is especially beneficial for patients with diabetes, given its low dextrose content. Patients with diabetes using the product retain more control over their glucose levels than those who use traditional nutrition solutions and experience less need for insulin administration.

Patients battling obesity also benefit from PROPLETE because of its minimal-calorie characteristics. Low levels of carbohydrates and the elimination of lipids help prevent exacerbating the overarching weight problem.